StockNote
YTC
Ho Chi Minh City Medical Import-Export Joint Stock Company (YTC), formerly known as the Drug Supply Company, was established in 1984. The company operates mainly in the field of business, import and export of pharmaceuticals and medical equipment. YTC is one of five enterprises assigned by the Ministry of Health to import and distribute toxic, addictive and psychotropic drugs. The company currently has 1 warehouse with an area of 2000m2 meeting international GSP standards. Some customers of YTC such as Tam Duc Heart Hospital, Ho Chi Minh City Heart Institute, VINAPHA Joint Stock Company, TIPHARCO Pharmaceutical Joint Stock Company...YTC has been traded on UPCOM market since August 2017.
YTC currently has a market capitalization of roughly VND 207 billion, placing it in the small-cap group on the Vietnamese stock market. Its current P/E of 19x is 25% below its own 5-year average (25,4x), suggesting the stock is trading cheaper than its historical norm. P/B stands at 1,3x, 77% below its multi-year average of 5,5x. Return on equity (ROE) is at 6,9%, down from 8,8% the year before. Its debt-to-equity ratio of 1,3x is moderate, reflecting a balanced capital structure. In 2025, revenue grew 32% year-on-year while after-tax profit grew 33%.
This note is generated automatically from the stock's real financial data, for reference only — not investment advice.
Revenue & Profit
Unit: VND billion. Growth (%) vs. previous period.
Market Cap
Unit: VND billion. Year-end values; current year uses latest session.
Debt / Equity
Unit: x. Financial debt over shareholders' equity.
Data aggregated from cafef.vn and VNDirect, for reference only, not investment advice.